Ask AI
S. 4378

Hatch-Waxman Improvement Act of 2022

Hatch-Waxman Improvement Act of 2022

This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sen. Marshall, Roger [R-KS](R-KS)Sponsor
1committees2actions1related bills
  1. IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. IntroReferral10000

    Introduced in Senate

Hatch-Waxman Improvement Act of 2022 — Informed